Skip to main content
. 2019 Nov 29;10:2777. doi: 10.3389/fmicb.2019.02777

Figure 3.

Figure 3

CFRs of achieving 50% fT > MIC, 50% fT > 2×MIC, and 50% fT > 5 × MIC for meropenem with various dosage regimens simulated for the targeted bacteria populations with pooled MIC distributions between 16 and 512 mg/L. AB, Acinetobacter baumannii; AS, Acinetobacter spp.; EFS, Enterococcus faecalis; EFM, Enterococcus faecium; PA, Pseudomonas aeruginosa; SE, Staphylococcus epidermidis; SHA, Staphylococcus haemolyticus; SM, Stenotrophomonas maltophilia; 50% fT > MIC, 50% of the dosing interval during which free drug concentrations remain above the MIC; 50% fT > 2 × MIC, 50% of the dosing interval during which free drug concentrations remain above the MIC by two-fold; 50% fT > 5 × MIC, 50% of the dosing interval during which free drug concentrations remain above the MIC by five-fold.